Full Length Research Paper
References
Ambler RP (1980). The structure of β-lactamases', Philosophical Transactions of the Royal Society of London. B, Biological Sciences 289(1036):321-331. |
|
Bahar G, Erac B, Mert A, Gülay Z (2004). PER-1 Production in a Urinary Isolate of Providencia rettgeri. Journal of Chemotherapy 16(4):343-346. |
|
Boerlin P, Reid-Smith RJ (2008). 'Antimicrobial resistance: its emergence and transmission. Animal Health Research Reviews 9(2):115-126. |
|
Cattoir V (2008). Les nouvelles beta-lactamases à spectre étendu (BLSE)'. Pathologie infectieuse en réanimation. MAPAR. P. 208. |
|
Dubois V, Poirel L, Marie C, Arpin C, Nordmann P, Quentin C (2002). 'Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa', Antimicrobial agents and chemotherapy. American Society for Microbiology 46(3):638-645. |
|
Feglo P, Adu-Sarkodie Y, Ayisi L, Jain R, Spurbeck RR, Springman AC, Walk ST (2013). Emergence of a Novel Extended-Spectrum-Lactamase ( ESBL ) - Pathogenic Escherichia coli in Kumasi, Ghana. Journal of Clinical Microbiology 51(2):728-730. |
|
Harbottle H, Thakur S, Zhao S, White DG (2006). Genetics of Antimicrobial Resistance. Animal Biotechnology 17(2):111-124. |
|
Herindrainy P, Randrianirina F, Ratovoson R, Hariniana ER, Buisson Y, Genel N, Richard V (2011). Rectal Carriage of Extended-Spectrum Beta-Lactamase-Producing Gram- Rectal Carriage of Extended-Spectrum Beta-Lactamase- Producing Gram-Negative Bacilli in Community Settings in Madagascar. PLoS ONE 6(7):e22738. |
|
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988). Extended Broad-Spectrum-Lactamases Conferring Transferable Resistance to Newer-Lactam Agents. Reviews of Infectious Disease 10(4):867-878. |
|
Kubo T, Kitabata H, Komukai K, Matsuo Y, Ozaki Y, Takarada S, Ueno S (2014). Corrigendum to " Occurrence of infection following prostate biopsy procedures in Japan : Japanese Research Group for Urinary Tract Infection ( JRGU ) e A multi-center retrospective study. Journal of Infection and Chemotherapy 20(10):660. |
|
Mètuor-dabiré A (2014). Caractérisations moléculaire et cinétique des types de β-lactamases à spectre élargi (BLSE) de souches bactériennes collectées au Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle (CHUP-CDG) de Ouagadougou', Thèse Présentée pour obtenir le grade de Docteur de l ' Université de Ouagadougou. |
|
Mètuor Dabiré A, Zongo J, Kaboré B, Zèba B, Baucher M, El Jaziri M, Simporé J (2018). Resistance to β-Lactamines by Gram Negative Bacteria, Producing Several Types of Enzymes , Isolated from Urines in Pediatric Center of Ouagadougou in Burkina Faso. International Journal of Microbiology and Biotechnology 3(4):95-98. |
|
Monnet DL (2000). Consommation d'antibiotiques et résistance bactérienne', in Annales françaises d'anesthésie et de réanimation. Elsevier, pp. 409-417. |
|
Munita JM, Arias CA (2016). Mechanisms of Antibiotic Resistance. Microbiology Spectrum 4(2):10.1128. |
|
Muylaert A, Mainil JG (2012). Résistances bactériennes aux antibiotiques : les mécanismes et leur «â€¯contagiosité. Université de Liège.   pp. 109-123. |
|
Naas T, Naas L, Nordmann P (2008). Minor extended-spectrum b -lactamases. Clinical Microbiology and Infection 14:42-52. |
|
Nordmann P, Naas L, Nordmann P (1993). Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37(5):962-969. |
|
Nordmann P, Naas T (1994). Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrobial Agents and Chemotherapy 38(1):104-114. |
|
Nugent R, Okeke IN (2010). Editorial When medicines fail : recommendations for curbing antibiotic resistance. Journal of Infection in Developing Countries 4(6):355-356 |
|
Ouedraogo A (2017). Prévalence, circulation et caractérisation des bactéries multirésistantes au Burkina Faso. Médecine humaine et pathologie. Université Montpellier, 2016. Français. ffNNT: 2016MONTT001ff. fftel-01476152 |
|
Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, Rossolini GM (2004). Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy. Journal of Clinical Microbiology 42(6):2523-2529. |
|
Pana ZD, Zaoutis T (2018). Treatment of extended-spectrum ?-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now? [version 1; peer review: 2 approved]', F1000Research 7(1347). doi: 10.12688/f1000research.14822.1. |
|
Pereira M, Perilli M, Mantengoli E, Luzzaro F, Toniolo A, Rossolini GM, Amicosante G (2000). PER-1 Extended-Spectrum β-Lactamase Production in an Alcaligenes faecalis Clinical Isolate Resistant to Expanded-Spectrum Cephalosporins and Monobactams from a Hospital in Northern Italy. Microbial Drug Resistance 6(1):85-90. |
|
Philippon A, Arlet G (2006). [Beta-lactamases of Gram negative bacteria: never-ending clockwork!]. Annales de Biologie Clinique 64(1):37-51. |
|
Pieboji JG (2007). Caractérisation des beta-lactamases et leur inhibition par les extraits de plantes médicinales. Thèse présentée en vue de l'obtention du diplôme de Doctorat ès Sciences en Biochimie. |
|
Poirel L, Le Thomas I, Naas, T, Karim A, Nordmann P (2000). 'Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum β-Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 44(3):622-632. |
|
Poirel L, Cabanne L, Vahaboglu H, Nordmann P (2005). Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria. Antimicrobial Agents and Chemotherapy 49(5):1708-1713. |
|
Vahaboglu H, Yaman A, Kaygusuz A (1996). Characterization of multiple-antibiotic-resistant Salmonella typhimurium stains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone. Journal of Clinical Microbiology 34(12):2942-2946. |
|
Vahaboglu H, Oztürk R, Aygün G, CoÅŸkunkan F, Yaman A, Kaygusuz A, Otkun M (1997). Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrobial Agents and Chemotherapy 41(10):2265-2269. |
|
Vodovar D, Marcadé G, Raskine L, Malissin I, Mégarbane B (2013). Entérobactéries productrices de bêta-lactamases à spectre élargi : épidémiologie, facteurs de risque et mesures de prévention. La Revue de Médecine Interne 34(11):687-693. |
|
Yong D, Shin JH, Kim S, Lim, Y, Yum JH, Lee K, Bauernfeind A (2003). High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea. Antimicrobial Agents and Chemotherapy 47(5):1749-1751. |
|
Zhuo C, Li, XQ, Zong ZY, Zhong, NS (2013). Epidemic Plasmid Carrying bla CTX-M-15 in Klebsiella penumoniae in China. PLoS ONE 8(1):1-8. |
|
Zongo KJ, Dabire AM, Compaore LG, Sanou I, Sangare L, Simpore J, Zeba, B (2015). First detection of bla TEM, SHV and CTX-M among Gram negative bacilli exhibiting extended spectrum β-lactamase phenotype isolated at University Hospital Center, Yalgado Ouedraogo, Ouagadougou, Burkina Faso. African Journal of Biotechnology 14(14):1174-1180. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0